Impact of upper gastrointestinal lesions in patients on low-dose aspirin therapy: Preliminary study

Journal of Gastroenterology and Hepatology (Australia)

Volumn 25, Issue SUPPL. 1, 2010, Pages

  Kawai, Takashi ^a   Watanabe, Masataka ^a   Yamashina, Akira ^a  

^a TOKYO MEDICAL UNIVERSITY HOSPITAL   (Japan)

Author keywords

Esophageal cancer; Gastric cancer; Low dose aspirin; Peptic ulcer; Reflux esophagitis; Transnasal esophagogastroduodenoscopy

Indexed keywords

ACETYLSALICYLIC ACID; CARDIOVASCULAR AGENT;

ABDOMINAL PAIN; AGED; CONFERENCE PAPER; DUODENUM INJURY; DUODENUM ULCER; ENDOSCOPY; ESOPHAGUS INJURY; ESOPHAGUS ULCER; FEMALE; GASTRODUODENAL ULCER; HELICOBACTER INFECTION; HUMAN; INDIGESTION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PRIORITY JOURNAL; RATING SCALE; REFLUX ESOPHAGITIS; STOMACH CANCER; STOMACH LESION; STOMACH ULCER; CHEMICALLY INDUCED; DIGESTIVE TRACT ENDOSCOPY; DUODENAL ULCER; ESOPHAGEAL NEOPLASMS; ESOPHAGITIS, PEPTIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; INCIDENCE; ISOLATION AND PURIFICATION; JAPAN; MICROBIOLOGY; MIDDLE AGED; PILOT STUDY; SEVERITY OF ILLNESS INDEX; STOMACH NEOPLASMS;

AGED; ASPIRIN; CARDIOVASCULAR AGENTS; DUODENAL ULCER; ENDOSCOPY, DIGESTIVE SYSTEM; ESOPHAGEAL NEOPLASMS; ESOPHAGITIS, PEPTIC; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; PILOT PROJECTS; SEVERITY OF ILLNESS INDEX; STOMACH NEOPLASMS; STOMACH ULCER;

EID: 77951538328     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2010.06225.x     Document Type: Conference Paper

References (36)

1. Antithrombitic Trialists' Collaboration. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002 324 : 71 86.
2. Iakovou I, Schmidt T, Bonizzoni E et al. Incidence, predictors and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005 292 : 2126 2130. (Pubitemid 40617065)
3. Antman EM, Anbe DT, Armstorong PW et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guideline for the Management of Patients with Acute Myocardial Infarction). Circulation 2004 110 : e82 292.
4. Weil J, Colin-Jones D, Langman M et al. Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ 1995 310 : 827 830.
5. Sorensen HT, Mellemkjaer L, Blot WJ et al. Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin. Am. J. Gastroenterol. 2000 95 : 2218 2224.
6. Derry S, Loke YK. Risk of gastrointestinal haemorrhage with long term use of aspirin meta-analysis. Br. Med. J. 2000 321 : 1183 1197.
7. Serrano P, Lanas A, Arroyo MT et al. Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for prevention of cardiovascular disease. Aliment. Pharmacol. Ther. 2002 16 : 1945 1953. (Pubitemid 34407526)
8. Chan FK, Ching JY, Hung LC et al. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. N. Engl. J. Med. 2005 20 : 238 244. (Pubitemid 40110812)
9. Irani S, Krevsky B, Desipio J et al. Rapid protection of the gastroduodenal mucosa against aspirin-induced damage by rabeprazole. Aliment. Pharmacol. Ther. 2008 15 : 498 503. (Pubitemid 351300855)
10. Vallurupalli NG, Goldhaber SZ. Gastrointestinal complications of dual antiplatelet therapy. Circulation 2006 28 : e655 8.
11. Bikner B, Fritz N, Schatke W, Hasford J. A prospective randomized comparison of unsedated ultrathin versus standard esophagogastroduodenoscopy in routine outpatient gastroenterology practice: does it work better through the nose. Endoscopy 2003 35 : 647 651. (Pubitemid 37028302)
12. Presss C, Charton JP, Schumacher B, Neuhaus H. A randomized trial of unsedated transnasal small-caliber esophagogastroduodenoscopy (EGD) versus peroral small-caliber EGD versus conventional EGD. Endoscopy 2003 35 : 641 645. (Pubitemid 37025141)
13. Kawai T, Miyazaki I, Yagi K et al. Comparison of the effects on cardiopulmonary function of ultrathin transnasal versus normal diameter transoral esophagogastroduodenoscopy in Japan. Hepatogastroenterology 2007 54 : 770 774. (Pubitemid 46903720)
14. Kawano T, Ogino K, Haruki S et al. Preparation and techniques of transnasal esophagogastroduodenoscopy. Gastroenterol. Endosc. 2007 49 : 1168 1174 (in Japanese).
15. Armstrong D, Bennett JR, Blum AL et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 1996 111 : 85 92. (Pubitemid 26226887)
16. Makuuchi H. Clinical study of esophageal hiatal hernia: diagnostic criteria and degree classification of hiatal hernia. J. Jpn. Soc. Gastroenterol. 1982 79 : 1157 1167 (in Japanese). (Pubitemid 13239015)
17. Yeomans ND, Lanas AI, Taley NJ et al. Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses aspirin. Aliment. Pharmacol. Ther. 2005 1 : 795 801.
18. Shiotani A, Sakakibara T, Yamanaka Y et al. Upper gastrointestinal ulcer in Japanese patients taking low-dose aspirin. J. Gastroenterol. 2009 44 : 126 131.
19. Ishikawa S, Inaba T, Mizuno M et al. Incidence of serious upper gastrointestinal bleeding in patients taking non-steroidal anti-inflammatory drug in Japan. Acta Med. Okayama 2008 62 : 29 36. (Pubitemid 351463555)
20. Sakamoto C, Sugano K, Ota S et al. Case-control study on the association of upper gastrointestinal bleeding and nonsteroidal anti-inflammatory drugs in Japan. Eur. J. Clin. Pharmacol. 2006 62 : 765 772. (Pubitemid 44289508)
21. Technology Committee of American Society for Gastrointestinal Endoscopy. Technology status evaluation report: ultrathin endoscopes esophagogastroduodenoscopy. Gastrointest. Endosc. 2000 51 : 786 789.
22. Miyaoka M, Abe K, Ogata T. Current status of transnasal esophagogastroduodenoscopy (EGD). Gastroenterol. Endosc. 2007 49 : 1402 1412. (Pubitemid 47092880)
23. Biondi-Zoccai GG, Lotrionte M, Agostoni P et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50.279 patients at risk for coronary artery disease. Eur. Heart J. 2006 27 : 2667 2674. (Pubitemid 44729867)
24. Taha AS, Angerson WJ, Knill-Jones RP, Blatchford O. Upper gastrointestinal mucosal abnormalities and blood loss complicating low-dose aspirin and antithrombotic therapy. Aliment. Pharmacol. Ther. 2006 15 : 489 495. (Pubitemid 43382003)
25. Taha AS, Angerson WJ, Morran CG. Correlation between erosive oesophagitis and gastro-duodenal diseases, the influence of aspirin, simple analgesics, and Helicobacter pylori. Eur. J. Gastroenterol. 2002 14 : 1313 1317.
26. Avidan B, Sonnenberg A, Schnell TG, Sontag SJ. Risk factors for erosive reflex esophagitis; a case-control study. Am. J. Gastroenterol. 2001 96 : 41 6. (Pubitemid 32104805)
27. Yeomans N, Lanas A, Labenz J et al. Efficacy of esomeprazole (20 mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirin. Am. J. Gastroenterol. 2008 103 : 1 9.
28. Haruma K, Hamada H, Mihara M et al. Negative association between Helicobacter pylori infection and reflux esophagitis in older patients: case-control study in Japan. Helicobacter 2001 5 : 24 9.
29. Mishima I, Adachi K, Arima N et al. Prevalence of endoscopically negative and positive gastroesophageal reflux disease in the Japanese. Scand. J. Gastroenterol. Hepatol. 2005 40 : 1005 1009. (Pubitemid 41291347)
30. Huang JQ, Sridhar S, Hunt RH. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analyisis. Lancet 2002 359 : 14 22. (Pubitemid 34119190)
31. Hunt RH, Bazzoli F. Review article: should NSAIDs/low-dose aspirin takers be tested routinely for H. pylori infection and treated if positive? Implications for primary risk of ulcer and ulcer relapse after initial healing. Aliment. Pharmacol. Ther. 2004 19 (Suppl. 1 9 16. (Pubitemid 38253486)
32. Inui Y, Ohwada S, Kondou Y, Sohara N, Yoshikawa M. Status and issues of mass screening for gastric cancer applying transnasal endoscopy - from the standpoint of screening for residents. Stomach Intest. 2008 43 : 1230 1240.
33. Husain SS, Szabo IL, Tamawski AS. NSAIDs inhibition of GI cancer growth clinical implications and molecular mechanisms of action. Am. J. Gastroenterol. 2002 97 : 542 553.
34. Baron JA, Sandler RS. Nonsteroidal anti-inflammatory drugs and cancer prevention. Annu. Rev. Med. 2000 51 : 511 523. (Pubitemid 30216052)
35. Duan L, Wu AH, Sullivan-Halley J, Bernstein L. Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric adenocarcinomas in Los Angeles County. Cancer. Epidemiol. Biomarkers Prev. 2008 17 : 126 134. (Pubitemid 351196282)
36. Fortuny J, Johnson CC, Bohlke K et al. Use of anti-inflammatory drugs and lower esophageal sphincter-relaxing drugs and risk of esophageal and gastric cancers. Clin. Gastroenterol. Hepatol. 2007 5 : 1154 1159. (Pubitemid 47488964)